Aethlon Hemopurifier captures immunosuppressive exosomes from people with metastatic melanoma.
Richard Winneker, SVP Study for LLS, stated, Although cure price for Hodgkin Lymphoma is normally high compared to other types of blood cancers, refractory and relapsed patients have few therapeutic options. More importantly current treatments for HL patients involve cytotoxic drug therapies and radiotherapy, which are likely responsible for secondary tumors and additional considerable long term unwanted effects developing afterwards in a patient's life, leaving open a critical dependence on more and safer durable therapies. LLS is committed to advancing breakthrough therapies, for patients with unmet medical requirements especially, and Affimed's immunotherapy is emerging seeing that a promising therapeutic option for HL sufferers. (more…)